Xact Kapitalforvaltning’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
$2.99M Sell
37,259
-6,424
-15% -$665K 0.06% 255
2019
Q4
$4.67M Sell
43,683
-727
-2% -$75.8K 0.08% 229
2019
Q3
$4.75M Buy
44,410
+1,692
+4% +$174K 0.09% 206
2019
Q2
$4.35M Buy
42,718
+2,019
+5% +$194K 0.09% 206
2019
Q1
$3.66M Buy
40,699
+22,847
+128% +$1.98M 0.08% 224
2018
Q4
$1.49M Sell
17,852
-15,696
-47% -$1.47M 0.04% 423
2018
Q3
$3.62M Hold
33,548
0.08% 243
2018
Q2
$3.69M Buy
33,548
+1,711
+5% +$178K 0.08% 246
2018
Q1
$3.19M Buy
31,837
+998
+3% +$102K 0.07% 280
2017
Q4
$3.04M Buy
30,839
+1,682
+6% +$159K 0.07% 284
2017
Q3
$2.73M Buy
29,157
+453
+2% +$48.1K 0.08% 296
2017
Q2
$3.19M Sell
28,704
-375
-1% -$39.6K 0.1% 235
2017
Q1
$2.85M Buy
29,079
+4,591
+19% +$438K 0.09% 254
2016
Q4
$2.25M Buy
24,488
+89
+0.4% +$7.67K 0.08% 285
2016
Q3
$2.06M Buy
+24,399
New +$2.05M 0.07% 296

Other funds holding DGX

Xact Kapitalforvaltning's DGX Position: Q1 2020 in Review

Xact Kapitalforvaltning reduced its Quest Diagnostics (DGX) stake by 15% in Q1 2020, selling an estimated $665K and leaving 37,259 shares worth $2.99M. The position accounts for 0.06% of the portfolio, ranked #255.

Xact Kapitalforvaltning first reported a position in DGX in Q3 2016 and has held it in 15 quarters since. The position peaked at $4.75M in Q3 2019. 715 funds tracked by Wall St. Rank hold DGX as of Q1 2020.

  • Xact Kapitalforvaltning held 37,259 shares of Quest Diagnostics worth $2.99M as of Q1 2020.
  • Xact Kapitalforvaltning sold 6,424 Quest Diagnostics shares in Q1 2020, an estimated $665K.
  • Quest Diagnostics made up 0.06% of Xact Kapitalforvaltning's portfolio in Q1 2020, its #255 holding.
  • Xact Kapitalforvaltning first reported a position in Quest Diagnostics in Q3 2016 and has held it in 15 quarters since.
  • Xact Kapitalforvaltning's Quest Diagnostics position peaked at $4.75M in Q3 2019.
  • 715 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2020.

Based on Xact Kapitalforvaltning's 13F filing for Q1 2020, filed 14 May 2020.